Group B Streptococcus vaccine development: present status and future considerations, with emphasis o...
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries [version 1; peer review: 2 approved]
About this item
Full title
Author / Creator
Publisher
England: Faculty of 1000 Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Faculty of 1000 Ltd
Subjects
More information
Scope and Contents
Contents
Globally, group B
Streptococcus (GBS) remains the leading cause of sepsis and meningitis in young infants, with its greatest burden in the first 90 days of life. Intrapartum antibiotic prophylaxis (IAP) for women at risk of transmitting GBS to their newborns has been effective in reducing, but not eliminating, the young infant GBS disease burden...
Alternative Titles
Full title
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries [version 1; peer review: 2 approved]
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8428d43b049a462c9d63ce15e9d14b52
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8428d43b049a462c9d63ce15e9d14b52
Other Identifiers
ISSN
2046-1402
E-ISSN
2046-1402
DOI
10.12688/f1000research.9363.1
